STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity

Combining different immunotherapy approaches is currently building the future of immunotherapy, with the view to maximize anti-tumoral efficacy for larger patient population. The KISIMA™ platform allows the development of protein-based cancer vaccines able to induce tumor-specific T cell response re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Rossi, Matteo, Carboni, Susanna, Di Berardino-Besson, Wilma, Riva, Erika, Santiago-Raber, Marie-Laure, Belnoue, Elodie, Derouazi, Madiha
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8283310/
https://ncbi.nlm.nih.gov/pubmed/34276686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.695056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky